US Stock MarketDetailed Quotes

GMVDW G MEDICAL INNOVATIONS HLDGS LTD C/WTS 30/06/2025 (TO PUR COM)

Watchlist
  • 7.0400
  • 0.00000.00%
Close Aug 24 16:00 ET
0Market Cap0.00P/E (TTM)

G MEDICAL INNOVATIONS HLDGS LTD C/WTS 30/06/2025 (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Total revenue
-10.91%4.42M
1.24%4.96M
-11.33%4.9M
80.47%5.53M
2,709.17%3.06M
109K
Operating revenue
-10.91%4.42M
1.24%4.96M
-11.33%4.9M
80.47%5.53M
2,709.17%3.06M
--109K
Cost of revenue
5.33%3.64M
-18.45%3.45M
-26.37%4.23M
42.62%5.75M
249.00%4.03M
1.16M
Gross profit
-48.05%784K
126.24%1.51M
399.10%667K
76.99%-223K
7.36%-969K
-1.05M
Operating expense
125.97%28.19M
-3.78%12.48M
3.27%12.97M
-22.57%12.56M
-36.35%16.22M
25.48M
Selling and administrative expenses
158.08%24.86M
23.51%9.63M
0.03%7.8M
-41.26%7.8M
-47.03%13.27M
--25.06M
-Selling and marketing expense
----
----
----
----
--664K
----
-General and administrative expense
158.08%24.86M
23.51%9.63M
0.03%7.8M
-38.17%7.8M
-49.68%12.61M
--25.06M
Research and development costs
36.43%2.29M
27.76%1.68M
-48.47%1.32M
950.21%2.55M
-0.41%243K
--244K
Depreciation amortization depletion
9.93%487K
-87.55%443K
85.99%3.56M
-26.76%1.91M
1,384.09%2.61M
--176K
-Depreciation and amortization
9.93%487K
-87.55%443K
85.99%3.56M
-26.76%1.91M
1,384.09%2.61M
--176K
Provision for doubtful accounts
-22.68%559K
144.26%723K
0.34%296K
--295K
----
----
Other operating expenses
----
----
----
----
--88K
----
Operating profit
-149.91%-27.41M
10.83%-10.97M
3.75%-12.3M
25.63%-12.78M
35.21%-17.18M
-26.52M
Net non-operating interest income expense
148.69%1.92M
-465.90%-3.93M
80.62%-695K
-2,518.25%-3.59M
78.63%-137K
-641K
Non-operating interest income
----
----
----
-69.35%263K
204.26%858K
--282K
Non-operating interest expense
----
----
----
286.93%3.85M
7.80%995K
--923K
Total other finance cost
-148.69%-1.92M
465.90%3.93M
--695K
----
----
----
Other net income (expense)
3,614.79%11.55M
29.58%311K
240K
Gain on sale of security
3,614.79%11.55M
29.58%311K
--240K
----
----
----
Income before tax
4.44%-13.94M
-14.83%-14.59M
22.36%-12.71M
5.51%-16.37M
36.23%-17.32M
-27.16M
Income tax
633.33%16K
83.33%-3K
97.90%-18K
-148.41%-857K
-505.88%-345K
85K
Net income
-68.36%-25.07M
-17.34%-14.89M
18.19%-12.69M
8.64%-15.51M
37.70%-16.98M
-27.25M
Net income continuous Operations
4.31%-13.96M
-14.97%-14.59M
18.19%-12.69M
8.64%-15.51M
37.70%-16.98M
---27.25M
Net income discontinuous operations
-3,590.37%-11.11M
---301K
--0
----
----
----
Minority interest income
-236.15%-437K
14.47%-130K
-152K
-190K
Net income attributable to the parent company
-66.89%-24.63M
-17.72%-14.76M
19.17%-12.54M
8.64%-15.51M
37.26%-16.98M
-27.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.89%-24.63M
-17.72%-14.76M
19.17%-12.54M
8.64%-15.51M
37.26%-16.98M
-27.06M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017
Total revenue -10.91%4.42M1.24%4.96M-11.33%4.9M80.47%5.53M2,709.17%3.06M109K
Operating revenue -10.91%4.42M1.24%4.96M-11.33%4.9M80.47%5.53M2,709.17%3.06M--109K
Cost of revenue 5.33%3.64M-18.45%3.45M-26.37%4.23M42.62%5.75M249.00%4.03M1.16M
Gross profit -48.05%784K126.24%1.51M399.10%667K76.99%-223K7.36%-969K-1.05M
Operating expense 125.97%28.19M-3.78%12.48M3.27%12.97M-22.57%12.56M-36.35%16.22M25.48M
Selling and administrative expenses 158.08%24.86M23.51%9.63M0.03%7.8M-41.26%7.8M-47.03%13.27M--25.06M
-Selling and marketing expense ------------------664K----
-General and administrative expense 158.08%24.86M23.51%9.63M0.03%7.8M-38.17%7.8M-49.68%12.61M--25.06M
Research and development costs 36.43%2.29M27.76%1.68M-48.47%1.32M950.21%2.55M-0.41%243K--244K
Depreciation amortization depletion 9.93%487K-87.55%443K85.99%3.56M-26.76%1.91M1,384.09%2.61M--176K
-Depreciation and amortization 9.93%487K-87.55%443K85.99%3.56M-26.76%1.91M1,384.09%2.61M--176K
Provision for doubtful accounts -22.68%559K144.26%723K0.34%296K--295K--------
Other operating expenses ------------------88K----
Operating profit -149.91%-27.41M10.83%-10.97M3.75%-12.3M25.63%-12.78M35.21%-17.18M-26.52M
Net non-operating interest income expense 148.69%1.92M-465.90%-3.93M80.62%-695K-2,518.25%-3.59M78.63%-137K-641K
Non-operating interest income -------------69.35%263K204.26%858K--282K
Non-operating interest expense ------------286.93%3.85M7.80%995K--923K
Total other finance cost -148.69%-1.92M465.90%3.93M--695K------------
Other net income (expense) 3,614.79%11.55M29.58%311K240K
Gain on sale of security 3,614.79%11.55M29.58%311K--240K------------
Income before tax 4.44%-13.94M-14.83%-14.59M22.36%-12.71M5.51%-16.37M36.23%-17.32M-27.16M
Income tax 633.33%16K83.33%-3K97.90%-18K-148.41%-857K-505.88%-345K85K
Net income -68.36%-25.07M-17.34%-14.89M18.19%-12.69M8.64%-15.51M37.70%-16.98M-27.25M
Net income continuous Operations 4.31%-13.96M-14.97%-14.59M18.19%-12.69M8.64%-15.51M37.70%-16.98M---27.25M
Net income discontinuous operations -3,590.37%-11.11M---301K--0------------
Minority interest income -236.15%-437K14.47%-130K-152K-190K
Net income attributable to the parent company -66.89%-24.63M-17.72%-14.76M19.17%-12.54M8.64%-15.51M37.26%-16.98M-27.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.89%-24.63M-17.72%-14.76M19.17%-12.54M8.64%-15.51M37.26%-16.98M-27.06M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg